R D Lawrence Lecture 2010. The brain as a target organ in Type 2 diabetes: exploring the links with cognitive impairment and dementia. (Q48541090)

12 February 2018

title

R D Lawrence Lecture 2010. The brain as a target organ in Type 2 diabetes: exploring the links with cognitive impairment and dementia. (English)

1 reference

12 February 2018

main subject

type 2 diabetes

0 references

dementia

0 references

cognitive dysfunction

1 reference

M W J Strachan

1

1 reference

12 February 2018

publication date

1 February 2011

1 reference

12 February 2018

published in

Diabetic Medicine

1 reference

12 February 2018

volume

28

1 reference

12 February 2018

issue

2

1 reference

12 February 2018

page(s)

141-147

1 reference

12 February 2018

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03199.X

Risk of dementia in diabetes mellitus: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03199.X

Cognitive decline and dementia in diabetes--systematic overview of prospective observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03199.X

Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03199.X

The symptoms of hyperglycaemia in people with insulin-treated diabetes: classification using principal components analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03199.X

Acute hyperglycemia alters mood state and impairs cognitive performance in people with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03199.X

Relationships between hyperglycemia and cognitive performance among adults with type 1 and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03199.X

Improving metabolic control leads to better working memory in adults with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03199.X

Postprandial plasma glucose excursions and cognitive functioning in aged type 2 diabetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03199.X

Long-term effect of diabetes and its treatment on cognitive function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03199.X

Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03199.X

Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03199.X

Effects of intensive glucose lowering in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03199.X

Increased blood-brain barrier permeability in type II diabetes demonstrated by gadolinium magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03199.X

Basal ganglia calcification in BB/E rats with diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03199.X

Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: a rationale based on homology between cerebral and retinal microvasculatures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03199.X

Retinal arterial changes correlate with cerebral small-vessel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03199.X

Cerebral white matter lesions, retinopathy, and incident clinical stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03199.X

Retinal microvascular abnormalities and MRI-defined subclinical cerebral infarction: the Atherosclerosis Risk in Communities Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03199.X

Retinal microvascular signs and cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03199.X

Retinal microvascular signs, cognitive function, and dementia in older persons: the Cardiovascular Health Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03199.X

Retinal microvascular abnormalities and cognitive decline: the ARIC 14-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03199.X

Retinal microvascular abnormalities and cognitive dysfunction: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03199.X

Cognitive ability and brain structure in type 1 diabetes: relation to microangiopathy and preceding severe hypoglycemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03199.X

Metabolic and vascular determinants of impaired cognitive performance and abnormalities on brain magnetic resonance imaging in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03199.X

Diabetes, cognitive impairment, and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03199.X

The Edinburgh Type 2 Diabetes Study: study protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03199.X

Diabetic retinopathy and cognitive decline in older people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03199.X

Essential hypertension and cognitive function. The role of hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03199.X

Insulin and cognitive function in an elderly population. The Rotterdam Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03199.X

Hyperinsulinemia and cognitive decline in a middle-aged cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03199.X

Plasma C-peptide levels and rates of cognitive decline in older, community-dwelling women without diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03199.X

Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: cross sectional population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03199.X

Insulin and cognitive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03199.X

Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03199.X

Memory improvement following induced hyperinsulinemia in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03199.X

Intranasal insulin improves cognition and modulates beta-amyloid in early AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03199.X

Rosiglitazone reverses memory decline and hippocampal glucocorticoid receptor down-regulation in an Alzheimer's disease mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03199.X

Rosiglitazone rescues memory impairment in Alzheimer's transgenic mice: mechanisms involving a reduced amyloid and tau pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03199.X

Severe hypoglycaemia and cognitive impairment in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03199.X

Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03199.X

Severe hypoglycaemia and cognitive impairment in older patients with diabetes: the Fremantle Diabetes Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03199.X

Glucose intolerance, hyperinsulinaemia and cognitive function in a general population of elderly men

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.03199.X

10.1111/J.1464-5491.2010.03199.X

21 January 2018

Identifiers

DOI

1 reference

12 February 2018

PubMed ID

21219420

1 reference

12 February 2018